| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
Submitted on December 27, 2005
Accepted on May 19, 2006
Neuroendocrine Unit (KKM, EEL, JM, MM, EAL, SKG, and AK) and the Eating Disorders Unit (D.B.H.), Massachusetts General Hospital and Department of Internal Medicine, Beth Israel Deaconess Medical Center (S.Gl.), Harvard Medical School, Boston, Massachusetts 02114; and Wilkins Center for Eating Disorders (D.M.), Greenwich, Connecticut 06831
* To whom correspondence should be addressed. E-mail: KKMiller{at}Partners.org.
Context: Anorexia Nervosa (AN) is complicated by severe bone loss. The effects of persistent undernutrition and consequent neuroendocrine dysfunction on bone mass and the factors influencing skeletal recovery have not been well-characterized.
Object: To determine the rate of bone loss at the spine and hip in women with AN and whether resumption of menstrual function and/or improvement in weight are determinants of skeletal recovery in AN.
Design: Longitudinal
Setting: Clinical Research Center
Study Participants: 75 ambulatory women with AN
Main Outcome Measures: BMD and body composition were measured with DXA (Hologic 4500, Waltham, MA).
Results: In women not receiving oral contraceptives, those who did not improve weight or resume menses had a mean annual rate of decline of 2.6% at the spine and 2.4% at the hip. Those who resumed menses and improved weight had a mean annual increase of 3.1% at the PA spine and 1.8% at the hip. Women who recovered menses, demonstrated a mean increase of PA spine, but not hip, BMD, independent of weight gain. Women who improved weight, regardless of whether they recovered menstrual function, demonstrated a mean increase of hip, but not spine, BMD. Increase in fat-free mass was a more significant determinant of increased BMD than weight or fat mass gain. In women receiving oral contraceptives, there was no increase in BMD at any site despite a mean 11.7% weight increase.
Conclusions: These data suggest that rapid bone loss, at an average annual rate of about 2.5%, occurs in young women with active AN. Resumption of menstrual function is important for spine BMD recovery, whereas weight gain is critical for hip BMD recovery. We did not observe an increase in BMD with weight gain in women receiving oral contraceptives. Therefore, improvements in reproduction function and weight - with increases in lean body mass a critical component - are both necessary for skeletal recovery in women with AN.
This article has been cited by other articles:
![]() |
A. Giustina, G. Mazziotti, and E. Canalis Growth Hormone, Insulin-Like Growth Factors, and the Skeleton Endocr. Rev., August 1, 2008; 29(5): 535 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
L K Micklesfield, J Hugo, C Johnson, T D Noakes, and E V Lambert Factors associated with menstrual dysfunction and self-reported bone stress injuries in female runners in the ultra- and half-marathons of the Two Oceans Br. J. Sports Med., October 1, 2007; 41(10): 679 - 683. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Lata and M. E. Elliott Patient Assessment in the Diagnosis, Prevention, and Treatment of Osteoporosis Nutr Clin Pract, June 1, 2007; 22(3): 261 - 275. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |